Chimeric antigen receptor modified hematopoietic stem cells (CAR-HSCs) arm all immune forces for anti-tumor in mice. [PDF]
Wang T +9 more
europepmc +1 more source
Magnetic soft robots offer promise in biomedicine due to their wireless actuation and rapid response, but current fabrication methods are complex and have limited cellular compatibility. A new, contactless bioassembly strategy using hydrodynamic instabilities is introduced, enabling customizable, centimeter‐scale robots.
Wei Gao +5 more
wiley +1 more source
Microvesicles secreted by CoCl<sub>2</sub>-primed mesenchymal stromal cells boost the functionality of hematopoietic stem cells cultured with them. [PDF]
Pendse S, Kale V, Vaidya A.
europepmc +1 more source
Disentangling Coincident Cell Events Using Deep Transfer Learning and Compressive Sensing
Overlapping cells during detection distort single‐cell measurements and reduce diagnostic accuracy. A hybrid framework combining a fully convolutional neural network with compressive sensing to disentangle overlapping signals directly from raw time‐series data is presented.
Moritz Leuthner +2 more
wiley +1 more source
A reference model of circulating hematopoietic stem cells across the lifespan with applications to diagnostics. [PDF]
Furer N +26 more
europepmc +1 more source
Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis
Pamela Quaranta +33 more
openalex +1 more source
Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy
Early cardiac biomarker monitoring in AML induction therapy showed significantly higher hsTnT levels after daunorubicin 90 mg/m2 compared with 60 mg/m2, indicating a dose‐dependent early myocardial effect. ABSTRACT Anthracyclines are an essential component of induction therapy for acute myeloid leukemia (AML), but their optimal dosing and the ...
Stefan Markus Dendorfer +44 more
wiley +1 more source
Clusterin drives myeloid bias in aged hematopoietic stem cells by regulating mitochondrial function. [PDF]
Sun N +7 more
europepmc +1 more source
Case report: Spontaneous remission of severe aplastic anemia mediated by mutant hematopoietic stem cells evading T-cell attack. [PDF]
Shiroshita K +10 more
europepmc +1 more source
ABSTRACT The COMMANDS trial established luspatercept as a first‐line treatment for anemia in transfusion‐dependent lower‐risk (LR) myelodysplastic syndromes (MDS). Here we report red blood cell (RBC) transfusion response analysis based on somatic mutations profile and disease risk for patients treated with luspatercept or epoetin alfa in the COMMANDS ...
Rami S. Komrokji +9 more
wiley +1 more source

